Juvenile Idiopathic Arthritis
📧 Sign up to get email alerts when something new happens for Juvenile Idiopathic Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-01-23FDA Approved: CELECOXIB — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' generic celecoxib as an Original Application (ANDA210071), enabling market entry for this COX-2 in…
-
FDA approval · 2017-12-21FDA Approved: DOLEX FLEX — Original Application (Pharmadel LLC)
FDA approved DOLEX FLEX (ibuprofen) through Pharmadel LLC's original ANDA.
-
FDA approval · 2017-12-14FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ XR (tofacitinib) filed by Pfizer Laboratories Div Pfizer Inc, enabling the extended-rele…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease [Phase 4]
Phase 4 clinical trial evaluating the immune response to HPV vaccination in patients with autoimmune diseases. The study includes Juvenile I…
-
CLINICAL_TRIALS trial_result · 2017-10-04Clinical Trial Update: A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA) [Phase 4]
Phase 4 safety study of VIMOVO in adolescents with Juvenile Idiopathic Arthritis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-08-22FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for ALEVE GELCAPS (naproxen sodium) by Bayer HealthCare LLC., expanding the product through a supple…
-
CLINICAL_TRIALS research · 2017-07-31Clinical Trial Update: Use of Thermal and 3D Imaging to Quantify Arthritis
A completed clinical trial update describes using thermal imaging and 3D imaging to quantify arthritis. The study focused on rheumatoid arth…
-
FDA approval · 2017-06-30FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for ORENCIA (abatacept) submitted by E.R. Squibb & Sons, L.L.C. This action updates the product labe…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: An Internet-based Self-management Program for Adolescents With Arthritis [NA]
This document provides a completion update for a clinical trial evaluating an internet-based self-management program for adolescents with ju…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA) [Phase 1]
Phase 1 study evaluating subcutaneous tocilizumab in participants with polyarticular-course juvenile idiopathic arthritis has completed, wit…
-
FDA approval · 2017-03-10FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)
FDA approved a supplemental application for Naproxen by Zameer Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis [Phase 3]
Phase 3 trial evaluating a web-based pain self-management program for adolescents with Juvenile Idiopathic Arthritis has completed and resul…
-
FDA approval · 2017-03-07FDA Approved: METHOTREXATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for METHOTREXATE SODIUM from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS withdrawal · 2017-03-06Clinical Trial Update: Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα [Phase 3]
A Phase 3 trial evaluating antiviral prophylaxis for HBsAg-positive or HBcAb-positive/HBsAb-negative patients starting anti-TNF therapy has …
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis [Phase 4]
This Phase 4 study evaluated the pharmacokinetics of sulfasalazine in children with Juvenile Idiopathic Arthritis and was terminated; result…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis [Phase 3]
Phase 3 trial results for BMS-188667 in children and adolescents with juvenile idiopathic arthritis have been completed and are posted.
-
FDA approval · 2017-01-11FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)
The FDA approved a supplemental application for OTREXUP (methotrexate) filed by Antares Pharma, Inc. This update expands the regulatory auth…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan [Phase 3]
Phase 3 trial assessing intravenous abatacept for active polyarticular-course juvenile idiopathic arthritis in Japan completed with results …
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: OHRQoL Evaluation After Functional Therapy in JIA Patients [NA]
This clinical trial update reports on oral health-related quality of life evaluation after functional therapy in patients with Juvenile Idio…
-
CLINICAL_TRIALS research · 2016-12-30Clinical Trial Update: Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics
This clinical trial investigates methotrexate for Juvenile Idiopathic Arthritis guided by pharmacogenomics and pharmacometrics. The trial st…
-
CLINICAL_TRIALS research · 2016-12-05Clinical Trial Update: Oxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopathic Arthritis. Case-control Study and Cases Treated / Cases Not Treated With Anti-TNFα [NA]
This clinical trial update examines substrate oxidation during exercise in children and adolescents with juvenile idiopathic arthritis, comp…
-
CLINICAL_TRIALS research · 2016-11-28Clinical Trial Update: Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients [NA]
This clinical trial update investigates predicting and analyzing the clinical relevance of anti-biopharmaceutical immunization to minimize i…
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Video-Based Task Oriented Activity Training in Patients With Juvenile Idiopathic Arthritis [NA]
The clinical trial update indicates completion of a study evaluating video-based task-oriented activity training for patients with Juvenile …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core Study [Phase 3]
This document reports a long-term extension study of tocilizumab (RoActemra/Actemra) in pediatric patients with Juvenile Idiopathic Arthriti…
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA [Phase 3]
A Phase 3 clinical trial evaluating Vitamin D and calcium supplementation, alone or together, on calcium absorption and bone mineral content…